Okubo Y, Bessho K, Fujimura K, Kaihara S, Iizuka T, Miyatake S
Department of Oral and Maxillofacial Surgery, Graduate School of Medicine, Kyoto University, Japan.
Life Sci. 2001 Dec 7;70(3):325-36. doi: 10.1016/s0024-3205(01)01393-5.
We evaluated the time course of osteoinduction by an adenoviral vector, AxCAOBMP-2, in normal rats (Group I) and 2 immunosuppressed groups (Groups II and III). Immunosuppression was induced by 125 mg/kg of cyclophosphamide injected intraperitoneally the day before vector injection. Groups I and III received a high dose of AxCAOBMP-2 (25 microl; 8.75 x 10(8) pfu) and Group II a low dose (5 microl; 1.75 x 10(8) pfu). Each dose of AxCAOBMP-2 was injected into the right calf muscle of rats. On days 7, 14 and 21 postinjection, the osteoinducive activity in each group was investigated radiologically, histologically, immunohistochemically and biochemically. Osteoinduction was observed only in Groups II and III on days 14 and 21. The activity of osteoinduction in Group III was higher than that in Group II. There was little difference in the expression of LacZ between Groups I and III on day 3. However, there was a marked difference in BMP-2 protein expression between Groups I and III on day 7 postinjection. We speculated that the reason for this was that most of the infected cells were eliminated by the immune system of the host from days 3 to 7. These results suggest that gene therapy with AxCAOBMP-2 under transient immunosuppression may be useful for bone reconstruction.
我们评估了腺病毒载体AxCAOBMP - 2在正常大鼠(I组)和2个免疫抑制组(II组和III组)中骨诱导的时间进程。在注射载体前一天,通过腹腔注射125 mg/kg环磷酰胺诱导免疫抑制。I组和III组接受高剂量的AxCAOBMP - 2(25微升;8.75×10⁸ 噬斑形成单位),II组接受低剂量(5微升;1.75×10⁸ 噬斑形成单位)。将每一剂量的AxCAOBMP - 2注射到大鼠的右小腿肌肉中。在注射后第7、14和21天,对每组的骨诱导活性进行放射学、组织学、免疫组织化学和生物化学研究。仅在II组和III组的第14天和21天观察到骨诱导。III组的骨诱导活性高于II组。在第3天,I组和III组之间LacZ的表达几乎没有差异。然而,在注射后第7天,I组和III组之间BMP - 2蛋白表达存在显著差异。我们推测其原因是从第3天到第7天,大多数感染细胞被宿主免疫系统清除。这些结果表明,在短暂免疫抑制下用AxCAOBMP - 2进行基因治疗可能对骨重建有用。